Community Outreach, Mark J. Holterman

IPSAC-VN Nonprofit Group Improves Pediatric Surgery In Vietnam


Mark J. Holterman, Medical

NIH Medical Scientist Training Program Funds Biomedical Research


MSTP pic

A professor of surgery and pediatrics at the University of Illinois College of Medicine, Dr. Mark Holterman formerly served as an attending pediatric surgeon at Rush University Medical Center and as the surgeon-in-chief at Advocate Children’s Hospital. Mark Holterman, MD, started his medical career at the University of Virginia in the National Institutes of Health Medical Scientist Training Program (MSTP).

Funded through the Ruth L. Kirschstein Grant, the MSTP program supports the training of qualified students who are seeking dual doctorates (MD and PhD) and are motivated to pursue biomedical research and other research-related careers in academia, industry, and government. Benefitting from an education that integrates biomedical sciences with clinical training, 900 trainees at 48 sites are funded through the MSTP program.

Students can choose research projects in a wide array of specialties, including biology, chemistry, behavioral science, and computer science. Those who prevail in the highly competitive grant selection process typically spend eight years obtaining their dual degrees. MSTP grant winners receive a stipend and tuition allowance.

Mark J. Holterman, Medical

Study – Enhanced Recovery Plan for Colorectal Surgical Patients


Dr. Mark J. Holterman pic
Dr. Mark J. Holterman

Mark Holterman, MD, serves as a professor of surgery and pediatrics at the University of Illinois College of Medicine in Peoria. Dr. Mark Holterman also is a fellow of the American College of Surgeons.

According to a recent study published by the American College of Surgeons, a new procedure for handling patient care through every stage of colorectal surgery not only helps these individuals have better outcomes, but also reduces the amount of time they have to stay in the hospital after surgery and results in lowered opioid pain medication usage.

In their study, researchers found that this new enhanced recovery program reduced hospital stays by an average of two days. Patients also were 14 percent less likely to develop abnormal bowel function and required 500-plus fewer units of morphine to manage their pain. The study’s lead author, Ian Paquette, MD, FACS, touted the results as a major breakthrough for surgeons and patients looking for better ways to handle recovery.

Mark J. Holterman, Medical

AACA Looks at Parametric Human


American Association of Clinical Anatomists  pic
American Association of Clinical Anatomists

A board-certified pediatric surgeon, Mark Holterman, MD, serves as a professor of surgery and pediatrics at the University of Illinois College of Medicine in Peoria. Active in the medical field outside of his work, Dr. Mark Holterman is a member of the American Association of Clinical Anatomists (AACA).

The AACA recently highlighted the work of a multidisciplinary team of doctors and data scientists that could fundamentally shift the way we doctors tailor individualized medical treatment. Dubbed the parametric human, researchers are close to developing a completely 3D-printable “virtual” human that can be customized with all the different musculoskeletal variations currently known.

Doctors would then be able to run diagnostic tests on this virtual human to potentially see how it can respond to certain types of treatment, eliminating the need for animal testing altogether. The group behind the project says the goal is to become intimately familiar with the human body, beyond the superficial diagrams and other data that is so often used in anatomical education.

Mark J. Holterman, Medical

About PAPS Membership


Pacific Association of Pediatric Surgeons pic
Pacific Association of Pediatric Surgeons

A longtime proponent of stem cell research and therapy, Mark Holterman, MD, serves as pediatrics professor at the University of Illinois College of Medicine in Peoria. Alongside his work, Dr. Mark Holterman belongs to the Pacific Association of Pediatric Surgeons (PAPS).

PAPS is an exclusive organization aimed at promoting fellowship and education among doctors who are from Pacific Rim nations. The organization currently has more than 500 members spanning 23 countries. Surgeons who spend more than 90 percent of their time in pediatric care are eligible to join the organization through geography and by invitation.

Potential applicants must either currently be practicing pediatric surgery in a Pacific-bordering country. If that surgeon moves away from the Pacific area, they can remain in the organizations by attending at least three PAPS meetings within the last decade. They must also be practicing pediatric surgeons for at least a year before becoming eligible to apply for membership.

Mark J. Holterman, Medical

American Diabetes Association Issues Joint Guidance on CGMs


American Diabetes Association pic
American Diabetes Association

Possessing decades of experience as both a physician and an educator, Mark Holterman, MD, serves as a professor of medicine at the University of Illinois College of Medicine. In addition to his work educating students, Dr. Mark Holterman is a longtime supporter of the American Diabetes Association.

Continuous glucose monitoring (CGM) systems provide people with diabetes real-time feedback about changes in their blood sugar levels. This helps them decide whether or not to eat different things or integrate some exercise into their daily routines. Even though these devices offer significant benefits to patients, they are not used as much as they could be, because a lack of standardized guidelines exist on how they should be prescribed. That’s why the American Diabetes Association has partnered with the European Association for the Study of Diabetes to issue a joint statement called “Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations.”

The new statement provides recommendations on marketing, clinical data reporting, and regulatory guidance, among other items. It can be found in the December 2017 edition of Diabetes Care and is based on a comprehensive examination of 50-plus scientific articles about CGMs.

Mark J. Holterman, Medical

Three Patient Benefits of Cellular Therapies


Mark J Holterman
Mark J Holterman

A pediatric surgeon with more than two decades of experience, Mark Holterman, MD, teaches medical students and residents at the University of Illinois College of Medicine and serves as the chief medical officer for Mariam Global Health. Dr. Mark Holterman also maintains an interest in stem cell therapy and has published numerous articles on the subject. Stem cell therapies offer multiple benefits to patients, as outlined below.

1. Treats a wide range of conditions. From cardiovascular and neurodegenerative diseases to orthopedic injuries, cellular therapies can treat a broad spectrum of medical conditions. Research indicates that cellular therapies can help stimulate the repair and growth of blood vessel tissues surrounding the heart and offer relief from degenerative symptoms associated with neurodegenerative diseases. Medical researchers also suspect that adult stem cells may possess the ability to help patients with autoimmune diseases and diabetes.

2. Promotes wound healing. Stem cell therapy accelerates tissue growth and boosts the body’s production of collagen, a protein found in skin, muscles, bones, blood vessels, and the digestive system that strengthens skin and replaces dead cells. The increase of collagen concentration tightens damaged tissue and reduces scars by growing healthy tissue.

3. Improved success for transplants. Cellular therapies give patients the option to transplant cells from one area of their body to another, which decreases the possibility of a rejection response.